The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
of course it is driven by this denovo lipogenesis which is why again we see this huge correlation between fatty liver which is a huge problem by the way it's actually causing a ton of cirrhosis these days and type-2 diabetes
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the two and threefold difference we see in de novo lipogenesis hepatic synthesis of fat impaired hepatic glucose sensitivity
it is a significant contributor to metabolic fatty liver disease and it's upregulated with peripheral sensitivity